Anizometropik ve İzoametropik Ambliyopili Olguların Kapama Tedavisi Sonuçlarının Karşılaştırılması

Year 2023, Volume: 10 Issue: 2, 90 - 97, 21.08.2023

Baybars Barış Başar , Vuslat Gürlü , Göksu Alaçamlı

https://doi.org/10.47572/muskutd.1037889

Abstract

Anizometropik ve izoametropik ambliyopili olgu gruplarında kapama tedavisi sonuçlarını karşılaştırmak amacıyla; Trakya Üniversitesi Tıp Fakültesi Göz Hastalıkları Ortoptik biriminde anizometropik veya izoametropik ambliyopi tanısıyla kapama tedavisi uygulanmış 74’ü anizometropik ve 73’ü izoametropik, toplam 147 ambliyop olguya ait dosya kayıtları retrospektif olarak incelendi. Çalışmaya alınan olguların ilk muayenelerine ve kapama tedavisi sonuçlarına ait bulgular, her iki ambliyopi grubunda birbirleri ile karşılaştırıldı ve kapama tedavisinin başarısını etkileyen faktörler araştırıldı. Olguların ambliyopi tespit yaşları medyan değerleri; izoametropik ambliyopi olgu grubunda 7.00, anziometropik ambliyopi olgu grubunda ise 7.50 yıl idi. Anizometropik ambliyoplarda izoametropik olgulara göre tanı yaşının daha yüksek, başlangıç görme keskinliğinin daha düşük ve kapama sürelerinin daha uzun olduğu tespit edildi. Tedavi sonucu üzerine etkili parametreler birlikte değerlendirildiğinde; tüm olgularda tedaviye başlama yaşının, kapama süresi ve tedavi süresinin başarı üzerine etkisi olmadığı, ilk görme keskinliğinin ise tedavi başarısını etkileyen en önemli faktör olduğu saptandı. Sonuç olarak, anizometropik ve izoametropik ambliyopili olgu grupları arasında ambliyopi tespit yaşları, ilk muayenedeki görme keskinlikleri ve uygulanan kapama süreleri farklılık göstermekle birlikte, kapama tedavisinin başarısı açısından iki olgu grubu arasında farklılık bulunmamıştır.

Keywords

Anizometropik Ambliyopi, İzoametropik Ambliyopi, Kapama Tedavisi

Supporting Institution

yok

Project Number

yok

The Comparison of Occlusion Therapy Results in Anisometropic and Isoametropic Amblyopia Cases

Abstract

In order to compare the results of occlusion therapy 147 patients with amblyopia who had been followed in the orthoptic department of Trakya University Ophthalmology Clinic were included in the study. The results of the occlusion therapy was compared between two amblyopia groups and the factors effecting the success of occlusion therapy were examined. 74 patients were diagnosed as anisometropic amblyopia and 73 patients were diagnosed as isoametropic amblyopia. In isoametropic amblyopia group median amblyopia diagnose age was 7.00 and in anisometropic amblyopia group median amblyopia diagnose age was 7.50 years. In anisometropic amblyopia group; diagnose age was higher, first visual acuity was lower and the duration of occlusion therapy was longer than the isoametropic amblyopia group. We found that the start of occlusion therapy age, daily duration of occlusion and total therapy time were not effecting the success of therapy. The first visual acuity was the most important factor that was effecting the success of occlusion therapy. As a result, in anisometropic and isoametropic amblyopia patients, amblyopia diagnose age, visual acuity at the first examination and the duration of occlusion showed differences. We found no difference between two groups in terms of occlusion therapy success.

Keywords

Anisometropic Amblyopia, İsoametropic Amblyopia, Occlusion Therapy

Project Number

yok

References

• 1. Von Noorden GK. Amblyopia. In: Lampert R. (Eds). Binocular vision and ocular motility. 6th ed. St Louis: CV Mosby Company; 2002. p.246-97.
• 2. Blair K, Cibis G, Gulani AC. Amblyopia. 2021 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 28613640.
• 3. Sen S, Singh P, Saxena R. Management of amblyopia in pediatric patients: Current insights. Eye. 2022;36(1):44-56.
• 4. Birch EE, Kelly KR, Wang J. Recent advances in screening and treatment for amblyopia. Ophthalmol Ther. 2021;10(4):815-30.
• 5. Koçak G, Duranoğlu Y. Ambliyopi ve tedavisi. Turk Oftalmol Gazetesi. 44(2):227-35.
• 6. Rutstein RP, Fuhr PS. Efficacy and stability of amblyopia therapy. Optom Vis Sci. 1992;69(10):747-54.
• 7. Eibschitz-Tsimhoni M, Friedman T, Naor J, et al. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS. 2000;4(4):194-9.
• 8. Brooks SE. Amblyopia. Ophthalmol Clin North Am. 1996:9;171-84.
• 9. Sanaç AŞ. Ambliyopi ve tedavisi. Şaşılık ve tedavisi. 2. baskı. Ankara: Pelin Ofset ve Tipo Matbaacılık; 2001. s.83-93.
• 10. Epelbaum M, Milleret C, Buisseret P, et al. The sensitive period for strabismic amblyopia in humans. Ophtalmology. 1993;100(3):323-7.
• 11. Hardman Lea SJ, Loades J, Rubinstein MP. The sensitive period for anisometropic amblyopia. Eye. 1989;3(6):783-90.
• 12. Sen DK. Results of treatment in amblyopia associated with unilateral high myopia without strabismus. Br J Ophtalmol. 1984;68(9):681-5.
• 13. Cobb CJ, Russell K, Cox A, et al. Factors influencing visual outcome in anisometropic amblyopes. Br J Ophtalmol. 2002;86:1278-81.
• 14. Sanaç AŞ. Binoküler görmenin değerlendirilmesi. Şaşılık ve tedavisi. 2. baskı. Ankara: Pelin Ofset ve Tipo Matbaacılık; 2001. s.61-81.
• 15. Özkan SB. Şaşılık ve tedavisi. Aydın P, Akova YA (Editörler). Temel göz hastalıkları. Ankara: Güneş Kitabevi; 2001. s.427-58.
• 16. Helveston EM. Relationship between degree of anisometropia and depth of amblyopia. Am J Ophthalmol. 1966;62:757-9.
• 17. Kutschke PJ, Scott WE, Keech RV: Anisometropic amblyopia. Ophtalmology. 1991;98:258-63.
• 18. Sen DK. Anisometropic amblyopia. J Pediatr Ophthalmol Strabismus. 1980;17:180-4.
• 19. Townshend AM, Holmes JM, Evans LS. Depth of anisometropic amblyopia and difference in refraction. Am J Ophthalmol. 1993;116:431-6.
• 20. Malik SRK, Gupta AK, Choudry S: Anisometropia. Its relation to amblyopia and eccentric fixation. Br J Ophthalmol. 1968;52:773-6.
• 21. Bengisu Ü. Şaşılık. Göz Hastalıkları. 4. baskı. Ankara: Palme Yayıncılık; 1998. s232-4.
• 22. Greenwald MJ. Refractive abnormalities in childhood. Pediatr Clin North Am. 2003;50(1):197-212.
• 23. Kanski JJ. Strabismus. Clinical Ophtalmology. 4th ed. London: Butterworth-Heinemann Ltd; 1999. p.514-50.
• 24. Mazow ML, Chuang A, Vital MC, et al. Outcome study in amblyopia: Treatment and practise pattern variations. J AAPOS. 2000;4:1-9.
• 25. Boniquet-Sanchez S, Sabater-Cruz N. Current management of amblyopia with new technologies for binocular treatment. Vision (Basel). 2021;5(2):31.
• 26. Pamukçu K. Şaşılıkların cerrahi dışı tedavi prensipleri. MN Oftalmoloji. 1997;4:414-9.
• 27. Güven S, Uzunel D, Köse S, et al. Ambliyopi tedavisinde CAM görme uyaranının etkinliği. Turk Oftalmol Derg. 2007;37(2):149-55.
• 28. Flynn JT, Schiffman J, Feuer W, et al. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Ophtalmol Soc. 1998;96:431-50.
• 29. Ohlsson J, Baumann M, Sjöstrand J, et al. Long term visual outcome in amblyopia treatment. Br J Ophthalmol. 2002;86:1148-51.
• 30. Lee SY, Isenberg SJ. The Relationship between stereopsis and visual acuity after occlusion therapy for amblyopia. Ophtalmology. 2003;110:2088-92.
• 31. Arıkan G, Yaman A, Berk T, et al. Ambliyopide kapama tedavisinin etkinliği ve tedavi sonucuna etkili risk faktörleri. Türkiye Klinikleri J Ophtalmol. 2004;13:150-8.
• 32. Uzunel D, Güven S, Köse, et al. Ambliyopide kapama tedavisinin etkinliği ve başarıyı etkileyen faktörler. Türkiye Klinikleri J Ophtalmol. 2007;16:1-8.
• 33. Singh I, Sachdrev N, Brar G, et al. Part time occlusion therapy for amblyopia in older children. Indian J Ophthalmol. 2008;56:459-63.
• 34. Lee YR, Lee JY. Part-time occlusion therapy for anisometropic amblyopia detected in children eight years of age and older. Korean J Ophthalmol. 2006;20(3):171-6.
• 35. Holmes JM, Melia M, Bradfield YS, et al. Factors associated with recurrence of amblyopia on cessation of patching. Ophthalmology. 2007;114(8):1427-32.
• 36. Rutstein RP, Corliss DA. Long-term changes in visual acuity and refractive error in amblyopes. Optom Vis Sci. 2004;81(7):510-5.
• 37. Migliorini R, Comberiati A.M, Pacella F, et al. Anisometropia and isoametropia associated with microstrabismus: Effectiveness of late anti-amblyopia treatment. Clin Ter. 2019;170(5):e339-44.
• 38. Pugh M. Foveal vision in amblyopia. Br J Ophtalmol. 1954;38:321-31.
• 39. Berk AT. Ambliyopi ve tedavisi. Türk Oftalmoloji Derneği Şaşılık Birimi (Editör). Şaşılık. İstanbul: Epsilon Yayıncılık; 2008. s.57-66.
• 40. Park KS, Chang YH, Na KD, et al. Outcomes of 6 hour part-time occlusion treatment combined with near activities for unilateral amblyopia. Korean J Ophthalmol. 2008;22:26-31.
• 41. Brar GS, Bandyopadhyay S, Kaushik S, et al. Efficiency of occlusion therapy for management of amblyopia in older children. Indian J Ophthalmol. 2006;54:257-60.
• 42. Stewart CE, Fielder AR, Stephens DA, et al. Treatment of unilateral amblyopia: Factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005;46:3152–60.
• 43. Levartovsky S, Oliver M, Gottesman N, et al. Factors affecting long term results of successfully treated amblyopia: initial visual acuity and type of amblyopia. Br J Ophthalmol. 1995;79:225-228.
• 44. Datta H, Choudhuri BR, Datta S. Visual evoked response in different types of amblyopia before and after occlusion therapy. J Indian Med Assoc. 1998;96(4):109-10.
• 45. Tacagni, DJ, Stewart, CE, Moseley, MJ, et al. Factors affecting the stability of visual function following cessation of occlusion therapy for amblyopia. Graefe's Arch Clin Exp Ophthalmol. 2007;245(6):811-6.
• 46. Beardsell R, Clarke S, Hill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophthalmol Strabismus. 1999;36(1):19-24.
• 47. Stewart CE, Stephens DA, Fielder AR; ROTAS Cooperative. Objectively monitored patching regimens for treatment of amblyopia: Randomised trial. BMJ. 2007;335(7622):707.
• 48. Woodruff G, Hiscox F, Thompson JR, et al. The presentation of children with amblyopia. Eye. 1994;8(6):623-6.
• 49. McNeil NL. Patterns on visual defects in children. Br J Ophtalmol. 1955;39(11):688- 701.
• 50. Chekitaan, Karthikeyan B, Meenakshi S. The results of treatment of anisomyopic and anisohypermetropic amblyopia. Int Ophtalmol. 2009;29:231-7.
• 51. Beardsell R, Clarke S, Hill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophtalmol Strabismus. 1999;36:19-24.
• 52. Scott WE, Kutschke PJ, Keech RV, et al. Amblyopia treatment outcomes. J AAPOS. 2005;9:107-11.
• 53. Repka MX, Beck RW, Holmes JM, et al. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophtalmol. 2003;121:603-11.